GP Microvascular
Introducing the Eyetelligence GP Microvascular eyescan, the latest in AI technology to assess your risk for vascular disease (including heart attack and stroke), using only a retinal image. It’s quick, easy and no blood tests are required.
Cardiovascular disease kills 1 in 4 Australians – that’s 1 person, every 12 minutes.* Know your risk and take action.
Early detection is key and it’s never been easier.
- a photo will be taken of your eyes, similar to having this done at an optometrist.
- the software scans your photo for features of cardiovascular disease.
- receive a report for your level of risk for developing cardiovascular disease within the next 5 years.
- discuss the results with your GP and steps you can take to mitigate your risk
Peace of mind and a take home report
Discuss the results with your doctor, then take home your easy to understand report and talk to your family about positive steps you can take to make a difference. The report shows your retinal age compared to your biological age, as well as your 5-year risk of developing cardiovascular events as a percentage. The report also gives you a comparison health status against other people with a similar age and gender to you.
Easy to track your progress
GP Microvascular makes it simple for non-invasive, regular monitoring and the opportunity for early intervention. In addition, the software can also analyse for features of the three leading causes of blindness; glaucoma, diabetic retinopathy and AMD. These results are included in your report.
Approved by medicines regulators and supported by the best
Latest News
Read about our latest updates and exciting product developments.
Retinal age gap as a predictive biomarker for mortality risk
The British Journal of Ophthalmology’s published excerpt for Eyetelligence’s Chief Medical Officer Prof. Ming He and team’s research in utilising retinal images to predict the microvascular health of an individual, using AI to generate a retinal age to compare with biological age.
Gap between ‘retinal age’ and real age may signal likelihood of death
Insight magazine explores the research published in the British Journal of Ophthalmology.